Literature DB >> 8378824

The pediatric inguinal hernia.

H B Othersen1.   

Abstract

(1) Think "little" when approaching the pediatric hernia. (2) The landmarks, incision, and operative technique are different from the approach in adults. (3) Do not operate unnecessarily. Delay correction of noncommunicating hydroceles in neonates for 3 to 4 months, and do not routinely explore the contralateral side unless there is suspicion of hernia. (4) For the usual hernia with minimal damage to the floor of the canal, high ligation of the sac and anatomic closure is all that is necessary. (5) For moderate enlargement of the internal ring and consequent weakening of the floor, imbrication techniques to reinforce the floor as well as high ligation of the sac will suffice. (6) Finally, with very large hernias and complete destruction of the floor of the inguinal canal, a major procedure such as the McVay herniorrhaphy will be necessary.

Entities:  

Mesh:

Year:  1993        PMID: 8378824     DOI: 10.1016/s0039-6109(16)46088-3

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  4 in total

1.  Preperitoneal approach for herniotomy in infants: a 9-year review.

Authors:  Vasu Karri; Darren Klass; Sattar Alshryda; Azad Mathur
Journal:  Pediatr Surg Int       Date:  2006-08-30       Impact factor: 1.827

2.  The role of preoperative antibiotics in the prevention of wound infection after day case surgery for inguinal hernia in children in Ile Ife, Nigeria.

Authors:  U E Usang; O A Sowande; O Adejuyigbe; T I B Bakare; O A Ademuyiwa
Journal:  Pediatr Surg Int       Date:  2008-08-23       Impact factor: 1.827

3.  Patent Contralateral Processus Vaginalis in Infants and Children: Is Herniotomy Justified?

Authors:  Ossama M Zakaria
Journal:  Oman Med J       Date:  2018-11

4.  Inguinal hernia repair with or without mesh in late adolescent males.

Authors:  Sung Hyun Kim; Hong Sung Jung; Sejin Park; Sang Sik Cho
Journal:  Ann Surg Treat Res       Date:  2021-03-30       Impact factor: 1.859

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.